Roman Hájek is Professor of Oncology, Head of the Department of Haematooncology in the University Hospital Ostrava and Vice-Rector for Strategy and Development at the University of Ostrava, Czech Republic. After qualifying in medicine in 1988 from J.E. Purkyne /Masaryk/ University Faculty of Medicine Brno, Dr Hajek received a PhD in haematology in 1995 and completed degrees in Internal Medicine in 1996, in Medical Oncology in 1998 and in Hematology in 2011.
Prof. Hájek is also Head of the Blood Cancer Research Group (BCRG) - international research team, joint project of the Medical Faculty, University of Ostrava and the Hematooncology Department, University Hospital Ostrava with a number of national and international collaborations.
Dr Hájek is chairman and a founding member of the Czech Myeloma Group. RMG Registry of Monoclonal Gammopathy of CMG is one of the largest registry focused on monoclonal gammopathies in the world.
Dr Hájek has published over 460 scientific articles (h-index: 43) and book chapters and is an editor of the European Journal of Hematology. His research interests include multiple myeloma and other monoclonal gammopathies, bone marrow transplantation, and immunotherapy.